IGFBP2 and coronary artery disorder: Indeed, some smaller studies failed to identify the association of BP1-BP2 deletion with CHD, reflecting the challenge of obtaining sufficient statistical power in the face of such variable penetrance and phenotypic heterogeneity (Cox and Butler, 2015).